GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NU Skin Enterprises NUS · USD

Consumer Staples · US listing · 🇺🇸 United States

Compare

4.28

+4.39%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

NU Skin Enterprises annual report

Filed with the US Securities and Exchange Commission

10-K

The latest annual report covers the year to 31 Dec 2025, filed on 13 Feb 2026.

Read the 10-K on SEC.gov ↗

Five-year highlights

In USD.

FY2025FY2024FY2023FY2022FY2021
Revenue$1.49bn$1.73bn$1.97bn$2.23bn$2.70bn
Operating income$90.9m−$148.6m$48.3m$102.5m$234.0m
Net income$160.2m−$146.6m$8.6m$104.8m$147.3m
Free cash flow$46.0m$70.2m$60.1m$49.0m$73.0m
Total assets$1.41bn$1.47bn$1.81bn$1.82bn$1.91bn
Shareholders' equity$805.2m$651.5m$822.0m$897.3m$912.8m

Revenue by business

Year to 31 Dec 2025

  • Wellness products developed and distributed under the Pharmanex brand. $689.1m · 46.4%
  • Beauty products developed and distributed under the Nu Skin brand. $568.1m · 38.3%
  • Other products and services, including household products and technology services. $228.0m · 15.4%

Revenue by region

Year to 31 Dec 2018

  • Consists of Australia, Canada, Latin America, New Caledonia, New Zealand and the United States. $385.0m · 14.4%
  • South Korea [Member] $373.4m · 13.9%
  • United States [Member] $311.4m · 11.6%
  • Japan [Member] $254.9m · 9.5%
  • Includes the manufacturing and product-packaging companies that the Company acquired during the first quarter of 2018, as well as the Company's indoor growing technology initiative. $94.0m · 3.5%

Filings

Newest first, from SEC EDGAR

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.